NEOPLASMS, COLON
Clinical trials for NEOPLASMS, COLON explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, COLON trials appear
Sign up with your email to follow new studies for NEOPLASMS, COLON, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an immunotherapy boost shrink colon tumors before surgery?
Disease control Recruiting nowThis study is testing if adding an immunotherapy drug called dostarlimab to standard chemotherapy works better than chemotherapy alone when given before colon cancer surgery. The goal is to see if the combination shrinks tumors more effectively in patients with a specific type of…
Matched conditions: NEOPLASMS, COLON
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Immunotherapy trial aims to boost survival in High-Risk colon cancer
Disease control Recruiting nowThis large, late-stage trial is testing whether a new immunotherapy drug called dostarlimab, given around the time of surgery, works better than standard chemotherapy for people with a specific type of colon cancer that has a high chance of returning. The study will enroll nearly…
Matched conditions: NEOPLASMS, COLON
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC